Atlas Trials

A Study to Evaluate Allogenic Bone-Marrow Mesenchymal Stromal Cell Product StromaForte in Aging Frailty Patients

Clinical trial NCT06063590 · COMPLETED

Trial details

NCT number
NCT06063590
Sponsor
Cellcolabs Clinical SPV Limited
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Aging Frailty
Start date
2024-01-22
Primary completion
2025-08-28
Enrollment
12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.